Search

Your search keyword '"DasGupta Bhaskar"' showing total 371 results

Search Constraints

Start Over You searched for: Author "DasGupta Bhaskar" Remove constraint Author: "DasGupta Bhaskar" Database Unpaywall Remove constraint Database: Unpaywall
371 results on '"DasGupta Bhaskar"'

Search Results

4. Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study

5. Development of a diagnostic prediction model for giant cell arteritis by sequential application of Southend Giant Cell Arteritis Probability Score and ultrasonography: a prospective multicentre study

7. Diagnostic accuracy of OGUS, Southend halo score and halo count in giant cell arteritis

10. Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trials

11. A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis

12. Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper

17. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update

18. The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial

20. Living in India

22. Early infection risk in patients with systemic lupus erythematosus treated with rituximab or belimumab from the British Isles Lupus Assessment Group Biologics Register (BILAG-BR): a prospective longitudinal study

23. Neural Networks

24. Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica

25. An international survey of current management practices for polymyalgia rheumatica by general practitioners and rheumatologists

26. The provisional OMERACT ultrasonography score for giant cell arteritis

33. Contribution of pathogenic T helper 1 and 17 cells to bursitis and tenosynovitis in polymyalgia rheumatica

35. Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial

37. Aetiology and pathogenesis

43. New-onset versus relapsing giant cell arteritis treated with tocilizumab: 3-year results from a randomized controlled trial and extension

49. OMERACT definition and reliability assessment of chronic ultrasound lesions of the axillary artery in giant cell arteritis

Catalog

Books, media, physical & digital resources